MedPath

南京海纳制药有限公司

Ownership
-
Established
2013-12-10
Employees
-
Market Cap
-
Website
http://www.pharmgarden.com/dt/index.aspx

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

7

NMPA:7

Drug Approvals

Potassium Chloride Granules

Product Name
氯化钾颗粒
Approval Number
国药准字H20254314
Approval Date
May 27, 2025
NMPA

Rivaroxaban Granules

Product Name
利伐沙班颗粒
Approval Number
国药准字H20254065
Approval Date
May 13, 2025
NMPA

Perampanel Tablets

Product Name
吡仑帕奈片
Approval Number
国药准字H20244188
Approval Date
Jun 28, 2024
NMPA

Perampanel Tablets

Product Name
吡仑帕奈片
Approval Number
国药准字H20244187
Approval Date
Jun 28, 2024
NMPA

Feprazone Tablets

Product Name
非普拉宗片
Approval Number
国药准字H20143420
Approval Date
Dec 27, 2019
NMPA

Azithromycin for Injection

Product Name
注射用阿奇霉素
Approval Number
国药准字H20093636
Approval Date
Jun 25, 2019
NMPA

Azithromycin for Injection

Product Name
注射用阿奇霉素
Approval Number
国药准字H20093637
Approval Date
Jun 25, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.